Global COVID-19 In-Vitro Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 113

Published Date: 06 Jan 2023

Category: New Technology

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The COVID-19 In-Vitro Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global COVID-19 In-Vitro Diagnostics market size will reach USD million in 2029, growing at a CAGR of % over the analysis period.

Market segmentation
COVID-19 In-Vitro Diagnostics market is split by Type and by Application. For the period 2023-2029, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Rapid Diagnostic Test (RDT)
    Enzyme Linked Immunosorbent Assay (ELISA)
    Neutralization Assay

Market segment by Application, can be divided into
    Home
    Hospital
    Clinical

Market segment by players, this report covers
    Cellex
    Abbott
    Roche
    BioMedomics
    BD
    Henry Schein
    Safecare Bio-Tech
    Mayo Clinic Laboratories
    Chembio Diagnostics
    Mount Sinai Laboratory
    Ortho Clinical Diagnostics
    Zhejiang Orient Gene Biotech
    Innovita Biological Technology
    Guangzhou Wondfo Biotech
    Guangdong Hecin-Scientific
    Dynamiker Biotechnology (Tianjin)
    ADVAITE

Market segment by regions, regional analysis covers
    North America
    Europe
    Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
    South America
    Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:
Chapter 1, to describe COVID-19 In-Vitro Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of COVID-19 In-Vitro Diagnostics, with recent developments and future plans
Chapter 3, the COVID-19 In-Vitro Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and COVID-19 In-Vitro Diagnostics market forecast, by regions, with revenue, from 2023 to 2029.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2023 to 2029.
Chapter 7 and 8, to describe COVID-19 In-Vitro Diagnostics research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of COVID-19 In-Vitro Diagnostics
    1.2 Classification of COVID-19 In-Vitro Diagnostics by Type
        1.2.1 Overview: Global COVID-19 In-Vitro Diagnostics Market Size by Type: 2022 Versus 2028
        1.2.2 Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Type in 2029
        1.2.3 Rapid Diagnostic Test (RDT)
        1.2.4 Enzyme Linked Immunosorbent Assay (ELISA)
        1.2.5 Neutralization Assay
    1.3 Global COVID-19 In-Vitro Diagnostics Market by Application
        1.3.1 Overview: Global COVID-19 In-Vitro Diagnostics Market Size by Application: 2023 Versus 2029
        1.3.2 Home
        1.3.3 Hospital
        1.3.4 Clinical
    1.4 Global COVID-19 In-Vitro Diagnostics Market Size & Forecast
    1.5 Market Drivers, Restraints and Trends
        1.5.1 COVID-19 In-Vitro Diagnostics Market Drivers
        1.5.2 COVID-19 In-Vitro Diagnostics Market Restraints
        1.5.3 COVID-19 In-Vitro Diagnostics Trends Analysis

2 Company Profiles
    2.1 Cellex
        2.1.1 Cellex Details
        2.1.2 Cellex Major Business
        2.1.3 Cellex COVID-19 In-Vitro Diagnostics Product and Solutions
        2.1.4 Cellex Recent Developments and Future Plans
    2.2 Abbott
        2.2.1 Abbott Details
        2.2.2 Abbott Major Business
        2.2.3 Abbott COVID-19 In-Vitro Diagnostics Product and Solutions
        2.2.4 Abbott Recent Developments and Future Plans
    2.3 Roche
        2.3.1 Roche Details
        2.3.2 Roche Major Business
        2.3.3 Roche COVID-19 In-Vitro Diagnostics Product and Solutions
        2.3.4 Roche Recent Developments and Future Plans
    2.4 BioMedomics
        2.4.1 BioMedomics Details
        2.4.2 BioMedomics Major Business
        2.4.3 BioMedomics COVID-19 In-Vitro Diagnostics Product and Solutions
        2.4.4 BioMedomics Recent Developments and Future Plans
    2.5 BD
        2.5.1 BD Details
        2.5.2 BD Major Business
        2.5.3 BD COVID-19 In-Vitro Diagnostics Product and Solutions
        2.5.4 BD Recent Developments and Future Plans
    2.6 Henry Schein
        2.6.1 Henry Schein Details
        2.6.2 Henry Schein Major Business
        2.6.3 Henry Schein COVID-19 In-Vitro Diagnostics Product and Solutions
        2.6.4 Henry Schein Recent Developments and Future Plans
    2.7 Safecare Bio-Tech
        2.7.1 Safecare Bio-Tech Details
        2.7.2 Safecare Bio-Tech Major Business
        2.7.3 Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product and Solutions
        2.7.4 Safecare Bio-Tech Recent Developments and Future Plans
    2.8 Mayo Clinic Laboratories
        2.8.1 Mayo Clinic Laboratories Details
        2.8.2 Mayo Clinic Laboratories Major Business
        2.8.3 Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product and Solutions
        2.8.4 Mayo Clinic Laboratories Recent Developments and Future Plans
    2.9 Chembio Diagnostics
        2.9.1 Chembio Diagnostics Details
        2.9.2 Chembio Diagnostics Major Business
        2.9.3 Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product and Solutions
        2.9.4 Chembio Diagnostics Recent Developments and Future Plans
    2.10 Mount Sinai Laboratory
        2.10.1 Mount Sinai Laboratory Details
        2.10.2 Mount Sinai Laboratory Major Business
        2.10.3 Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product and Solutions
        2.10.4 Mount Sinai Laboratory Recent Developments and Future Plans
    2.11 Ortho Clinical Diagnostics
        2.11.1 Ortho Clinical Diagnostics Details
        2.11.2 Ortho Clinical Diagnostics Major Business
        2.11.3 Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Product and Solutions
        2.11.4 Ortho Clinical Diagnostics Recent Developments and Future Plans
    2.12 Zhejiang Orient Gene Biotech
        2.12.1 Zhejiang Orient Gene Biotech Details
        2.12.2 Zhejiang Orient Gene Biotech Major Business
        2.12.3 Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Product and Solutions
        2.12.4 Zhejiang Orient Gene Biotech Recent Developments and Future Plans
    2.13 Innovita Biological Technology
        2.13.1 Innovita Biological Technology Details
        2.13.2 Innovita Biological Technology Major Business
        2.13.3 Innovita Biological Technology COVID-19 In-Vitro Diagnostics Product and Solutions
        2.13.4 Innovita Biological Technology Recent Developments and Future Plans
    2.14 Guangzhou Wondfo Biotech
        2.14.1 Guangzhou Wondfo Biotech Details
        2.14.2 Guangzhou Wondfo Biotech Major Business
        2.14.3 Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Product and Solutions
        2.14.4 Guangzhou Wondfo Biotech Recent Developments and Future Plans
    2.15 Guangdong Hecin-Scientific
        2.15.1 Guangdong Hecin-Scientific Details
        2.15.2 Guangdong Hecin-Scientific Major Business
        2.15.3 Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Product and Solutions
        2.15.4 Guangdong Hecin-Scientific Recent Developments and Future Plans
    2.16 Dynamiker Biotechnology (Tianjin)
        2.16.1 Dynamiker Biotechnology (Tianjin) Details
        2.16.2 Dynamiker Biotechnology (Tianjin) Major Business
        2.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Product and Solutions
        2.16.4 Dynamiker Biotechnology (Tianjin) Recent Developments and Future Plans
    2.17 ADVAITE
        2.17.1 ADVAITE Details
        2.17.2 ADVAITE Major Business
        2.17.3 ADVAITE COVID-19 In-Vitro Diagnostics Product and Solutions
        2.17.4 ADVAITE Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global COVID-19 In-Vitro Diagnostics Revenue and Share by Players (2023 & 2029)
    3.2 COVID-19 In-Vitro Diagnostics Players Head Office, Products and Services Provided
    3.3 COVID-19 In-Vitro Diagnostics Mergers & Acquisitions
    3.4 COVID-19 In-Vitro Diagnostics New Entrants and Expansion Plans

4 Global COVID-19 In-Vitro Diagnostics Forecast by Region
    4.1 Global COVID-19 In-Vitro Diagnostics Market Size by Region: 2023 VS 2029
    4.2 Global COVID-19 In-Vitro Diagnostics Market Size by Region, (2023-2029)
    4.3 North America
        4.3.1 Key Companies of COVID-19 In-Vitro Diagnostics in North America
        4.3.2 Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in North America
        4.3.3 North America COVID-19 In-Vitro Diagnostics Market Size and Prospect (2023-2029)
    4.4 Europe
        4.4.1 Key Companies of COVID-19 In-Vitro Diagnostics in Europe
        4.4.2 Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in Europe
        4.4.3 Europe COVID-19 In-Vitro Diagnostics Market Size and Prospect (2023-2029)
    4.5 Asia-Pacific
        4.5.1 Key Companies of COVID-19 In-Vitro Diagnostics in Asia-Pacific
        4.5.2 Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in Asia-Pacific
        4.5.3 Asia-Pacific COVID-19 In-Vitro Diagnostics Market Size and Prospect (2023-2029)
        4.5.4 China
        4.5.5 Japan
        4.5.6 South Korea
    4.6 South America
        4.6.1 Key Companies of COVID-19 In-Vitro Diagnostics in South America
        4.6.2 Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in South America
        4.6.3 South America COVID-19 In-Vitro Diagnostics Market Size and Prospect (2023-2029)
    4.7 Middle East & Africa
        4.7.1 Key Companies of COVID-19 In-Vitro Diagnostics in Middle East & Africa
        4.7.2 Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in Middle East & Africa
        4.7.3 Middle East & Africa COVID-19 In-Vitro Diagnostics Market Size and Prospect (2023-2029)

5 Market Size Segment by Type
    5.1 Global COVID-19 In-Vitro Diagnostics Market Forecast by Type (2023-2029)
    5.2 Global COVID-19 In-Vitro Diagnostics Market Share Forecast by Type (2023-2029)

6 Market Size Segment by Application
    6.1 Global COVID-19 In-Vitro Diagnostics Market Forecast by Application (2023-2029)
    6.2 Global COVID-19 In-Vitro Diagnostics Market Share Forecast by Application (2023-2029)

7 Research Findings and Conclusion

8 Appendix
    8.1 Methodology
    8.2 Research Process and Data Source
    8.3 Disclaimer

Table of Figures

List of Tables
Table 1. Global COVID-19 In-Vitro Diagnostics Revenue by Type, (USD Million), 2023 VS 2029
Table 2. Global COVID-19 In-Vitro Diagnostics Revenue by Application, (USD Million), 2023 VS 2029
Table 3. Cellex Corporate Information, Head Office, and Major Competitors
Table 4. Cellex Major Business
Table 5. Cellex COVID-19 In-Vitro Diagnostics Product and Solutions
Table 6. Abbott Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Major Business
Table 8. Abbott COVID-19 In-Vitro Diagnostics Product and Solutions
Table 9. Roche Corporate Information, Head Office, and Major Competitors
Table 10. Roche Major Business
Table 11. Roche COVID-19 In-Vitro Diagnostics Product and Solutions
Table 12. BioMedomics Corporate Information, Head Office, and Major Competitors
Table 13. BioMedomics Major Business
Table 14. BioMedomics COVID-19 In-Vitro Diagnostics Product and Solutions
Table 15. BD Corporate Information, Head Office, and Major Competitors
Table 16. BD Major Business
Table 17. BD COVID-19 In-Vitro Diagnostics Product and Solutions
Table 18. Henry Schein Corporate Information, Head Office, and Major Competitors
Table 19. Henry Schein Major Business
Table 20. Henry Schein COVID-19 In-Vitro Diagnostics Product and Solutions
Table 21. Safecare Bio-Tech Corporate Information, Head Office, and Major Competitors
Table 22. Safecare Bio-Tech Major Business
Table 23. Safecare Bio-Tech COVID-19 In-Vitro Diagnostics Product and Solutions
Table 24. Mayo Clinic Laboratories Corporate Information, Head Office, and Major Competitors
Table 25. Mayo Clinic Laboratories Major Business
Table 26. Mayo Clinic Laboratories COVID-19 In-Vitro Diagnostics Product and Solutions
Table 27. Chembio Diagnostics Corporate Information, Head Office, and Major Competitors
Table 28. Chembio Diagnostics Major Business
Table 29. Chembio Diagnostics COVID-19 In-Vitro Diagnostics Product and Solutions
Table 30. Mount Sinai Laboratory Corporate Information, Head Office, and Major Competitors
Table 31. Mount Sinai Laboratory Major Business
Table 32. Mount Sinai Laboratory COVID-19 In-Vitro Diagnostics Product and Solutions
Table 33. Ortho Clinical Diagnostics Corporate Information, Head Office, and Major Competitors
Table 34. Ortho Clinical Diagnostics Major Business
Table 35. Ortho Clinical Diagnostics COVID-19 In-Vitro Diagnostics Product and Solutions
Table 36. Zhejiang Orient Gene Biotech Corporate Information, Head Office, and Major Competitors
Table 37. Zhejiang Orient Gene Biotech Major Business
Table 38. Zhejiang Orient Gene Biotech COVID-19 In-Vitro Diagnostics Product and Solutions
Table 39. Innovita Biological Technology Corporate Information, Head Office, and Major Competitors
Table 40. Innovita Biological Technology Major Business
Table 41. Innovita Biological Technology COVID-19 In-Vitro Diagnostics Product and Solutions
Table 42. Guangzhou Wondfo Biotech Corporate Information, Head Office, and Major Competitors
Table 43. Guangzhou Wondfo Biotech Major Business
Table 44. Guangzhou Wondfo Biotech COVID-19 In-Vitro Diagnostics Product and Solutions
Table 45. Guangdong Hecin-Scientific Corporate Information, Head Office, and Major Competitors
Table 46. Guangdong Hecin-Scientific Major Business
Table 47. Guangdong Hecin-Scientific COVID-19 In-Vitro Diagnostics Product and Solutions
Table 48. Dynamiker Biotechnology (Tianjin) Corporate Information, Head Office, and Major Competitors
Table 49. Dynamiker Biotechnology (Tianjin) Major Business
Table 50. Dynamiker Biotechnology (Tianjin) COVID-19 In-Vitro Diagnostics Product and Solutions
Table 51. ADVAITE Corporate Information, Head Office, and Major Competitors
Table 52. ADVAITE Major Business
Table 53. ADVAITE COVID-19 In-Vitro Diagnostics Product and Solutions
Table 54. Global COVID-19 In-Vitro Diagnostics Revenue (USD Million) by Players (2023 & 2029)
Table 55. Global COVID-19 In-Vitro Diagnostics Revenue Share by Players (2023 & 2029)
Table 56. COVID-19 In-Vitro Diagnostics Players Head Office, Products and Services Provided
Table 57. COVID-19 In-Vitro Diagnostics Mergers & Acquisitions in the Past Five Years
Table 58. COVID-19 In-Vitro Diagnostics New Entrants and Expansion Plans
Table 59. Global Market COVID-19 In-Vitro Diagnostics Revenue (USD Million) Comparison by Region (2023 VS 2029)
Table 60. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Region (2023-2029)
Table 61. Key Companies of COVID-19 In-Vitro Diagnostics in North America
Table 62. Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in North America
Table 63. Key Companies of COVID-19 In-Vitro Diagnostics in Europe
Table 64. Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in Europe
Table 65. Key Companies of COVID-19 In-Vitro Diagnostics in Asia-Pacific
Table 66. Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in Asia-Pacific
Table 67. Key Companies of COVID-19 In-Vitro Diagnostics in China
Table 68. Key Companies of COVID-19 In-Vitro Diagnostics in Japan
Table 69. Key Companies of COVID-19 In-Vitro Diagnostics in South Korea
Table 70. Key Companies of COVID-19 In-Vitro Diagnostics in South America
Table 71. Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in South America
Table 72. Key Companies of COVID-19 In-Vitro Diagnostics in Middle East & Africa
Table 73. Current Situation and Forecast of COVID-19 In-Vitro Diagnostics in Middle East & Africa
Table 74. Global COVID-19 In-Vitro Diagnostics Revenue Forecast by Type (2023-2029)
Table 75. Global COVID-19 In-Vitro Diagnostics Revenue Forecast by Application (2023-2029)
List of Figures
Figure 1. COVID-19 In-Vitro Diagnostics Picture
Figure 2. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Type in 2029
Figure 3. Rapid Diagnostic Test (RDT)
Figure 4. Enzyme Linked Immunosorbent Assay (ELISA)
Figure 5. Neutralization Assay
Figure 6. COVID-19 In-Vitro Diagnostics Revenue Market Share by Application in 2029
Figure 7. Home Picture
Figure 8. Hospital Picture
Figure 9. Clinical Picture
Figure 10. Global COVID-19 In-Vitro Diagnostics Market Size, (USD Million): 2023 VS 2029
Figure 11. Global COVID-19 In-Vitro Diagnostics Revenue and Forecast (2023-2029) & (USD Million)
Figure 12. COVID-19 In-Vitro Diagnostics Market Drivers
Figure 13. COVID-19 In-Vitro Diagnostics Market Restraints
Figure 14. COVID-19 In-Vitro Diagnostics Market Trends
Figure 15. Cellex Recent Developments and Future Plans
Figure 16. Abbott Recent Developments and Future Plans
Figure 17. Roche Recent Developments and Future Plans
Figure 18. BioMedomics Recent Developments and Future Plans
Figure 19. BD Recent Developments and Future Plans
Figure 20. Henry Schein Recent Developments and Future Plans
Figure 21. Safecare Bio-Tech Recent Developments and Future Plans
Figure 22. Mayo Clinic Laboratories Recent Developments and Future Plans
Figure 23. Chembio Diagnostics Recent Developments and Future Plans
Figure 24. Mount Sinai Laboratory Recent Developments and Future Plans
Figure 25. Ortho Clinical Diagnostics Recent Developments and Future Plans
Figure 26. Zhejiang Orient Gene Biotech Recent Developments and Future Plans
Figure 27. Innovita Biological Technology Recent Developments and Future Plans
Figure 28. Guangzhou Wondfo Biotech Recent Developments and Future Plans
Figure 29. Guangdong Hecin-Scientific Recent Developments and Future Plans
Figure 30. Dynamiker Biotechnology (Tianjin) Recent Developments and Future Plans
Figure 31. ADVAITE Recent Developments and Future Plans
Figure 32. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Region (2023-2029)
Figure 33. Global COVID-19 In-Vitro Diagnostics Revenue Market Share by Region in 2029
Figure 34. North America COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2023-2029)
Figure 35. Europe COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2023-2029)
Figure 36. Asia-Pacific COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2023-2029)
Figure 37. South America COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2023-2029)
Figure 38. Middle East & Africa COVID-19 In-Vitro Diagnostics Revenue (USD Million) and Growth Rate (2023-2029)
Figure 39. Global COVID-19 In-Vitro Diagnostics Market Share Forecast by Type (2023-2029)
Figure 40. Global COVID-19 In-Vitro Diagnostics Market Share Forecast by Application (2023-2029)
Figure 41. Methodology
Figure 42. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Cellex
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE

Related Reports

Global COVID-19 In-Vitro Diagnostics Supply, Demand and Key Producers, 2023-2029

Global COVID-19 In-Vitro Diagnostics Supply, Demand and Key Producers, 2023-2029

date 16 Mar 2023

date New Technology

The global COVID-19 In-Vitro Diagnostics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global COVID-19 In-Vitro Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global COVID-19 In-Vitro Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 17 Jan 2024

date New Technology

According to our latest research, the global COVID-19 In-Vitro Diagnostics market size will reach USD million in 2030, growing at a CAGR of % over the analysis period.

Product Tags

COVID-19 In-Vitro Diagnostics

Ecobricks

Space Mining

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>